159 related articles for article (PubMed ID: 25185535)
1. Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.
Méndez-Sánchez N; Paraná R; Cheinquer H; Alves de Mattos A; Gadano A; Silva M; Pessôa MG; Gomes-Ferraz ML; Soza A; Mendes-Correa MC; Chávez-Tapia NC; Dagher L; Padilla M; Hernandez N; Sánchez-Avila JF; Contreras F; Moraes-Coelho HS; Parise ER; Bessone F; Uribe M;
Ann Hepatol; 2014 Aug; 13 Suppl 2():s4-66. PubMed ID: 25185535
[No Abstract] [Full Text] [Related]
2. Mexican consensus on the diagnosis and management of hepatitis C infection.
Sánchez-Ávila JF; Dehesa-Violante M; Méndez-Sánchez N; Bosques-Padilla F; Castillo-Barradas M; Castro-Narro G; Cisneros-Garza L; Chirino-Sprung RA; García-Juarez I; Gonzalez-Huezo MS; Malé-Velazquez R; Moreno-Alcántar R; Muñoz-Espinoza L; Ramos-Gómez M; Rizo-Robles MT; Sandoval-Salas R; Sierra-Madero J; Torres-Ibarra Mdel R; Vazquez-Frias R; Wolpert-Barraza E; ; ;
Ann Hepatol; 2015; 14 Suppl 1():5-48. PubMed ID: 25983318
[No Abstract] [Full Text] [Related]
3. Effect of ezetimibe in HCV viral load after liver transplantation.
Monrroy-Bravo H; Angulo J; Pino K; Labbé P; López-Lastra M; Soza A
Ann Hepatol; 2016; 15(5):803-5. PubMed ID: 27493122
[No Abstract] [Full Text] [Related]
4. Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents.
Suraweera D; Saab EG; Tong MJ; Saab S
Exp Clin Transplant; 2016 Jun; 14(3):243-51. PubMed ID: 27221717
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of post-transplant hepatitis C virus cirrhosis with daclatasvir and asunaprevir.
Ozaras R; Mete B; Yemisen M; Balkan II; Alkan M; Tabak F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):393-4. PubMed ID: 26405716
[No Abstract] [Full Text] [Related]
6. Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV-HCV genotype 1 coinfection.
Lison H; Garioud A; Halfon P; Jambon S; Cordier F; Verbrigghe C; Landgraf N; Pitre C; Nguyen-Khac E; Cadranel JF
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):486-7. PubMed ID: 26934415
[No Abstract] [Full Text] [Related]
7. Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.
Korda D; Lenard ZM; Gerlei Z; Jakab Z; Haboub-Sandil A; Wagner L; Varga M; Cseprekal O; Marton A; Horvathy D; Takacs S; Doros A; Mathe Z
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):27-32. PubMed ID: 29049126
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
Verucchi G; Calza L; Manfredi R; Chiodo F
Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience.
Faisal N; Yoshida EM; Bilodeau M; Wong P; Ma M; Burak KW; Al-Judaibi B; Renner EL; Lilly LB
Ann Hepatol; 2014; 13(5):525-32. PubMed ID: 25152985
[TBL] [Abstract][Full Text] [Related]
10. Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.
Ogawa E; Furusyo N; Murata M; Toyoda K; Hayashi T; Ura K
Liver Int; 2018 Jan; 38(1):76-83. PubMed ID: 28618152
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
12. Optimal management of patients with chronic hepatitis C and comorbidities.
Boccaccio V; Bruno S
Liver Int; 2015 Jan; 35 Suppl 1():35-43. PubMed ID: 25529086
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.
Moorman AC; Xing J; Rupp LB; Gordon SC; Spradling PR; Boscarino JA; Schmidt MA; Daida YG; Teshale EH; Holmberg SD;
Gastroenterology; 2018 Feb; 154(3):754-758. PubMed ID: 29360428
[No Abstract] [Full Text] [Related]
14. Are we nearing the end in the fight against hepatitis C?
Chua JV; Kottilil S
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):499-500. PubMed ID: 28335650
[No Abstract] [Full Text] [Related]
15. Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH).
Calleja JL; Macias J; Forns X; Garcia F; Berenguer M; Garcia Deltoro M; Buti M; Granados R; Carrion JA; Morano L; Fernandez I; Coste P; Pineda JA
Gastroenterol Hepatol; 2018 Nov; 41(9):597-608. PubMed ID: 30270150
[No Abstract] [Full Text] [Related]
16. Recent advances in prevention of hepatitis B recurrence after liver transplantation.
Xi ZF; Xia Q
World J Gastroenterol; 2015 Jan; 21(3):829-35. PubMed ID: 25624716
[TBL] [Abstract][Full Text] [Related]
17. Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.
Roche B; Roque-Afonso AM; Nevens F; Samuel D
Transplantation; 2015 Jul; 99(7):1321-34. PubMed ID: 26038873
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic Hepatitis C.
Güçlü E; Alan S; Karabay O
Turk J Gastroenterol; 2020 Apr; 31(4):344-345. PubMed ID: 32412906
[No Abstract] [Full Text] [Related]
20. Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients.
Vinaixa C; Aguilera V; Blanes M; Maupoey J; Berenguer M; Prieto M
Liver Transpl; 2018 Oct; 24(10):1476-1480. PubMed ID: 30359487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
